Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
12/31/2008 | EP2008529A1 Enzyme-containing candy |
12/31/2008 | EP2007906A2 Use of glis3 for preparing functional pancreatic beta-cells |
12/31/2008 | EP2007815A2 Mono- and bifunctional molecules with ability to bind to g protein-coupled receptors |
12/31/2008 | EP2007814A2 Single domain vhh antibodies against von willebrand factor |
12/31/2008 | EP2007804A2 Glp-1 compounds |
12/31/2008 | EP2007801A1 Binder for c-reactive protein |
12/31/2008 | EP2007794A1 Lysobactin amides |
12/31/2008 | EP2007790A1 Compounds and methods for the treatment of pain |
12/31/2008 | EP2007789A2 Hcv/hiv inhibitors and their uses |
12/31/2008 | EP2007788A2 Hcv inhibitors |
12/31/2008 | EP2007787A2 Hcv inhibitors comprising beta amino acids and their uses |
12/31/2008 | EP2007431A2 Topical drug delivery |
12/31/2008 | EP2007428A2 Method for using boc/cdo to modulate hedgehog signaling |
12/31/2008 | EP2007426A2 Uses and compositions for treatment of psoriatic arthritis |
12/31/2008 | EP2007417A1 Covalent factor vii-tissue factor complex |
12/31/2008 | EP2007416A2 Remedies for ischemia |
12/31/2008 | EP2007415A2 Combination of an anti-edb fibronectin domain antibody/il2 fusion protein and a further small molecule |
12/31/2008 | EP2007414A2 Compositions and methods for suppression of amyloid plaque formation associated with neurodegenerative disorders. |
12/31/2008 | EP2007413A2 Livestock management for improved reproductive efficiency |
12/31/2008 | EP2007412A2 Therapeutic target molecules for the development of novel medicaments for degenerative diseases |
12/31/2008 | EP2007410A1 Method of preventing or reducing the risk or incidence of cancer using neural thread protein based peptides |
12/31/2008 | EP2007409A1 Regulation of immune responses by modulation of the function of antigen presenting cells |
12/31/2008 | EP2007370A1 Novel composition for tumor growth control |
12/31/2008 | EP2007348A1 Paediatric amino acid solution for parenteral nutrition |
12/31/2008 | EP1824882A4 Osteoprotegerin variant proteins |
12/31/2008 | EP1750773B1 Drugs for the prevention or treatment of immunodeficiencies, autoimmune diseases or for the induction of immune tolerance |
12/31/2008 | EP1718662A4 Multiplex detection probes |
12/31/2008 | EP1718323A4 Binding peptidomimetics and uses of the same |
12/31/2008 | EP1708733B1 Use of barusiban for the preparation of a medicament for treating hypertension related to pregnancy |
12/31/2008 | EP1664095B1 Antimicrobial polypeptides |
12/31/2008 | EP1648923B1 Spatially-defined macrocycles incorporating peptide bond surrogates |
12/31/2008 | EP1628659B1 Use of poly-aminopyrrolecarboxamides in combination with a cyclodextrin in the prophylaxis and treatment of animal parasitosis |
12/31/2008 | EP1556518B1 Genes and polypeptides relating to human pancreatic cancers |
12/31/2008 | EP1549771B1 Method for diagnosing pancreatic cancer |
12/31/2008 | EP1549760B1 Sak: modulation of cellular proliferation for treatment of cancer |
12/31/2008 | EP1443960B1 Antigen arrays presenting il-5, il-13 or eotaxin for treatment of allergic eosinophilic diseases |
12/31/2008 | EP1412503B1 A fusion protein |
12/31/2008 | EP1309610B1 Peptide and peptide mimetic derivatives with integrin inhibitor properties ii |
12/31/2008 | EP1305039B1 Stable (fixed) forms of viral l1 capsid proteins, fusion proteins and uses thereof |
12/31/2008 | EP1294879B1 Thymic stromal lymphopoietin receptor molecules and uses thereof |
12/31/2008 | EP1294872B1 Human trp-like calcium channel protein-2 (tlcc-2) |
12/31/2008 | EP1287152B1 Human-bovine chimeric respiratory syncytial virus vaccines |
12/31/2008 | EP1283735B1 Method for the improvement of islet signaling in diabetes mellitus and for its prevention |
12/31/2008 | EP1268525B1 Macrocyclic ns3-serine protease inhibitors of hepatitis c virus comprising n-cyclic p2 moieties |
12/31/2008 | EP1266009B1 ANTI-EGFRvIII SCFVS WITH IMPROVED CYTOTOXICITY AND YIELD, IMMUNOTOXINS BASED THEREON, AND METHODS OF USE THEREOF |
12/31/2008 | EP1255850B1 Amplification of cyp24 and uses thereof |
12/31/2008 | EP1239042B1 Transposase and method of gene modification |
12/31/2008 | EP1212339B1 2'-o-acetamido modified monomers and oligomers |
12/31/2008 | EP1203239B1 Use of a polypeptide for detecting a pathological condition associated with multiple sclerosis |
12/31/2008 | EP1149169B1 Methods of use of a novel lysyl oxidase-related protein |
12/31/2008 | EP1113810B1 Methods of treating multiple myeloma and myeloma-induced bone resorption using antagonists of integrin / receptor binding |
12/31/2008 | EP1040119B1 Hemiasterlin analogs |
12/31/2008 | EP1032672B1 Dna19355 polypeptide, a tumor necrosis factor homolog |
12/31/2008 | EP1028751B1 Methods and compositions comprising glycoprotein glycoforms |
12/31/2008 | EP0964873B1 Use of glucagon-like peptide-1 (glp-1) or analogs to abolish catabolic changes after surgery |
12/31/2008 | EP0937153B1 Human monoclonal antibodies specific for hepatitis c virus (hcv) e2 antigen |
12/31/2008 | EP0912730B1 Conjugates of soluble peptidic compounds with membrane-binding agents |
12/31/2008 | EP0759937B2 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis c virus |
12/31/2008 | CN101336251A Neuregulin variants and methods of screening and using thereof |
12/31/2008 | CN101336248A Novel compounds which interact with PEA-15 |
12/31/2008 | CN101336111A Method for preparing a factor H concentrate and the use thereof in the form of a drug |
12/31/2008 | CN101334411A Screening for CXCR4 receptor antagonism polypeptides for treating breast carcinoma and its uses |
12/31/2008 | CN101334356A Gas sensors |
12/31/2008 | CN101333531A CXCR4 antagonist recombination protein SDF-1 beta P2G, preparation method and application thereof |
12/31/2008 | CN101333259A Preparation of <99m>Tc galactosyl human serum albumin fusion interferon of liver receptor developer and uses thereof |
12/31/2008 | CN101333258A Fusion polypeptide with antimicrobial and wound healing promoting function |
12/31/2008 | CN101333252A Decorin gene capable of restraining tumour cell from growing and transferring, preparation method and application thereof |
12/31/2008 | CN101333251A Artificial zinc finger protein transcription factor capable of starting A20 gene expression and use |
12/31/2008 | CN101333249A Echinocandin derivatives, preparation method and application as anti-fungal agents |
12/31/2008 | CN101333247A Antimicrobial peptide separated from skin of Northeast China brown frog and applications in antibacterials |
12/31/2008 | CN101333244A Protein purification by ion exchange chromatography |
12/31/2008 | CN101332295A Enteric-coated glucosinolates and beta-thioglucosidases |
12/31/2008 | CN101332294A Use of human-source adiponcetin globular segment for medicine for treating diabetes and ischemic heart disease |
12/31/2008 | CN101332293A High-calcium soft chewable tablets and production method |
12/31/2008 | CN101332292A Novel use of a peptide class of compound for treating non-neuropathic inflammatory pain |
12/31/2008 | CN101332226A Compound toxin expelling and antioxidation biology oral liquid and preparation method thereof |
12/31/2008 | CN101332203A Medicine for preventing and curing porcine diarrhea |
12/31/2008 | CN101332169A Preparation method of thymopentin formulation for nasal administration |
12/31/2008 | CN100447245C Sodium-channel modulator Bmk a IV gene and its clonal and recombinant-protein expression |
12/31/2008 | CN100447244C BAFF receptor (BCMA), immunoregulatory agent |
12/31/2008 | CN100447159C Antibodies to ED-8 domain of fibronectin, their construction and uses |
12/31/2008 | CN100447157C Androgen receptor compound relative protein |
12/31/2008 | CN100447154C Use of HMG fragments as anti-inflammatory agents |
12/31/2008 | CN100447153C Preparing process and application of undecapeptide |
12/31/2008 | CN100447151C Peptide boronic acids useful in making salts thereof |
12/31/2008 | CN100447150C Isolation of lectins |
12/31/2008 | CN100446812C MVA expressing modified HIV envelope, GAG, and pol genes |
12/31/2008 | CN100446810C Non-neurotoxic plasminogen activating factors for treating stroke |
12/31/2008 | CN100446809C Injectable depot composition |
12/31/2008 | CA2728140A1 Peptide tyrosinase inhibitors and uses thereof |
12/31/2008 | CA2728122A1 Oligopeptide tyrosinase inhibitors and uses thereof |
12/31/2008 | CA2698143A1 Intravaginal drug delivery devices for the delivery of macromolecules and water-soluble drugs |
12/31/2008 | CA2694266A1 Labeled inhibitors of prostate specific membrane antigen (psma), biological evaluation, and use as imaging agents |
12/31/2008 | CA2692171A1 Methods and uses thereof of prosaposin |
12/31/2008 | CA2692053A1 Lyophilized anti-fungal composition |
12/31/2008 | CA2691784A1 Composition and method for treatment of autoimmune disease |
12/31/2008 | CA2691415A1 Tpp ii inhibitors for use in the treatment of autoimmune and inflammatory diseases and transplant rejection |
12/31/2008 | CA2691358A1 Influenza inhibiting compositions and methods |
12/31/2008 | CA2690371A1 Peptide having hypotensive activity |
12/31/2008 | CA2689960A1 Virosomes comprising hemagglutinin derived from an influenza virus produced in a cell line, compositions, methods of manufacturing, use thereof |